OliX PharmaceuticalsI (Korea) Top Management
226950 Stock | 19,620 630.00 3.11% |
OliX PharmaceuticalsI employs about 67 people. The company is managed by 3 executives with a total tenure of roughly 157 years, averaging almost 52.0 years of service per executive, having 22.33 employees per reported executive. Analysis of OliX PharmaceuticalsI's management performance can provide insight into the company performance.
SunWoo Hong Insider VP Director |
Shin Park Insider Sr Devel |
OliX |
OliX PharmaceuticalsI Management Team Effectiveness
The company has return on total asset (ROA) of (0.164) % which means that it has lost $0.164 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (76.6277) %, meaning that it generated substantial loss on money invested by shareholders. OliX PharmaceuticalsI's management efficiency ratios could be used to measure how well OliX PharmaceuticalsI manages its routine affairs as well as how well it operates its assets and liabilities.OliX PharmaceuticalsI Workforce Comparison
OliX PharmaceuticalsInc is rated third in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 576. OliX PharmaceuticalsI retains roughly 67.0 in number of employees claiming about 12% of stocks in Biotechnology industry.
OliX PharmaceuticalsInc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. OliX PharmaceuticalsInc Price Series Summation is a cross summation of OliX PharmaceuticalsI price series and its benchmark/peer.
OliX PharmaceuticalsI Notable Stakeholders
An OliX PharmaceuticalsI stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as OliX PharmaceuticalsI often face trade-offs trying to please all of them. OliX PharmaceuticalsI's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting OliX PharmaceuticalsI's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
SunWoo Hong | VP Director | Profile | |
Shin Park | Sr Devel | Profile | |
DongKi Lee | CEO Director | Profile |
About OliX PharmaceuticalsI Management Performance
The success or failure of an entity such as OliX PharmaceuticalsInc often depends on how effective the management is. OliX PharmaceuticalsI management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of OliX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the OliX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of OliX PharmaceuticalsI's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, OliX PharmaceuticalsI's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of OliX PharmaceuticalsI's management manipulating its earnings.
OliX PharmaceuticalsI Workforce Analysis
Traditionally, organizations such as OliX PharmaceuticalsI use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare OliX PharmaceuticalsI within its industry.OliX PharmaceuticalsI Manpower Efficiency
Return on OliX PharmaceuticalsI Manpower
Revenue Per Employee | 54.8M | |
Revenue Per Executive | 1.2B | |
Net Loss Per Employee | 451.9M | |
Net Loss Per Executive | 10.1B |
Complementary Tools for OliX Stock analysis
When running OliX PharmaceuticalsI's price analysis, check to measure OliX PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OliX PharmaceuticalsI is operating at the current time. Most of OliX PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of OliX PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OliX PharmaceuticalsI's price. Additionally, you may evaluate how the addition of OliX PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |